KORU Medical Systems Profit Margin 2012-2025 | KRMD
Current and historical gross margin, operating margin and net profit margin for KORU Medical Systems (KRMD) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. KORU Medical Systems net profit margin as of September 30, 2025 is -9.49%.
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.264B | $0.034B |
| KORU Medical Systems Inc. is a medical technology company. It focused on development, manufacturing and commercialization of patient-centric large volume subcutaneous infusion solutions. KORU Medical Systems Inc., formerly known as REPRO MEDSYSTEM, is based in MAHWAH, N.J. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $33.427B | 38.66 |
| Tempus AI (TEM) | United States | $10.416B | 0.00 |
| Doximity (DOCS) | United States | $7.021B | 28.91 |
| Hims & Hers Health (HIMS) | United States | $6.019B | 48.96 |
| IRhythm Holdings (IRTC) | United States | $5.017B | 0.00 |
| Privia Health (PRVA) | United States | $2.879B | 180.08 |
| Hinge Health (HNGE) | United States | $2.773B | 0.00 |
| 10x Genomics (TXG) | United States | $2.525B | 0.00 |
| Heartflow (HTFL) | United States | $2.451B | 0.00 |
| Omnicell (OMCL) | United States | $2.185B | 44.68 |
| Inspire Medical Systems (INSP) | United States | $2.134B | 35.31 |
| Azenta (AZTA) | United States | $1.726B | 70.81 |
| Enovis (ENOV) | United States | $1.268B | 6.66 |
| Clover Health Investments (CLOV) | United States | $1.137B | 0.00 |
| Schrodinger (SDGR) | United States | $1.038B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.965B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.807B | 0.00 |
| Phreesia (PHR) | United States | $0.796B | 0.00 |
| Talkspace (TALK) | United States | $0.683B | 137.33 |
| Standard BioTools (LAB) | United States | $0.542B | 0.00 |
| Claritev (CTEV) | United States | $0.459B | 0.00 |
| Evolent Health (EVH) | United States | $0.364B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.362B | 0.00 |
| Carlsmed (CARL) | United States | $0.331B | 0.00 |
| TruBridge (TBRG) | United States | $0.307B | 14.09 |
| Senseonics Holdings (SENS) | United States | $0.296B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.261B | 0.00 |
| CapsoVision (CV) | United States | $0.256B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.197B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.167B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.163B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.161B | 0.00 |
| CareCloud (CCLD) | United States | $0.114B | 6.28 |
| Outset Medical (OM) | United States | $0.090B | 0.00 |
| American Well (AMWL) | United States | $0.075B | 0.00 |
| Retrieve Medical Holdings (RMHI) | United States | $0.068B | 0.00 |
| Pulmonx (LUNG) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| NetraMark Holdings (AINMF) | Canada | $0.064B | 0.00 |
| HeartBeam (BEAT) | United States | $0.050B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.045B | 0.00 |
| Precipio (PRPO) | United States | $0.043B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.026B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.018B | 0.00 |
| Movano (MOVE) | United States | $0.012B | 0.00 |
| Zhongchao (ZCMD) | China | $0.011B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.011B | 0.00 |
| HeartSciences (HSCS) | United States | $0.010B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.008B | 0.00 |
| PROFUSA (PFSA) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.007B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.002B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |